Andrea Biju

Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial

Katherine V. Houser, Martin R. Gaudinski, Myra Happe et al. · EClinicalMedicine · 2022 · 44 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Molecular Characterisation of Titin N2A and Its Binding of CARP Reveals a Titin/Actin Cross-linking Mechanism

Tiankun Zhou, Jennifer R. Fleming, Stephan Lange et al. · Journal of Molecular Biology · 2021 · 41 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability

Jason Gorman, Crystal Sao‐Fong Cheung, Zhijian Duan et al. · Nature Communications · 2024 · 19 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization

Mallika Sastry, Anita Changela, Jason Gorman et al. · Journal of Virology · 2023 · 16 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases

Adam S. Olia, Cheng Cheng, Tongqing Zhou et al. · iScience · 2023 · 15 citations · Full text

Life Sciences, Immunology, Molecular Biology +17